Back to Search
LIDIA RUBINSTEIN, M.D.
M.D.
Gynecology Physician
NPI: 1598914681Individual
Specialties, Licenses & Credentials
Gynecology PhysicianPrimary
Obstetrics & Gynecology — Gynecology
Code: 207VG0400X
A24656(CA)
Research & Publications (20)
Design issues of randomized phase II trials and a proposal for phase II screening trials.
PMID 16192604·J Clin Oncol·2005
8-other
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experience.
PMID 19384685·J Biopharm Stat·2009
8-other
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies.
PMID 19364967·J Clin Oncol·2009
3-trial
Serologic assay to quantify human immunoglobulin G antibodies to the Staphylococcus aureus iron surface determinant B antigen.
PMID 19321693·Clin Vaccine Immunol·2009
8-other
Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum.
PMID 19158284·Clin Vaccine Immunol·2009
4-observational
Recommendations for the assessment of progression in randomised cancer treatment trials.
PMID 19097775·Eur J Cancer·2009
6-review
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
PMID 19097774·Eur J Cancer·2009
6-review
Individual patient data analysis to assess modifications to the RECIST criteria.
PMID 19095437·Eur J Cancer·2009
8-other
Validation of novel imaging methodologies for use as cancer clinical trial end-points.
PMID 19091547·Eur J Cancer·2009
4-observational
Preclinical modeling of a phase 0 clinical trial: qualification of a pharmacodynamic assay of poly (ADP-ribose) polymerase in tumor biopsies of mouse xenografts.
PMID 18980982·Clin Cancer Res·2008
7-preclinical
Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial.
PMID 18821408·J Immunoassay Immunochem·2008
7-preclinical
Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?
PMID 18669467·J Clin Oncol·2008
6-review
Hepatitis B testing and vaccination in patients recently diagnosed with HIV infection(Int J STD AIDS 2008;19:83-4).
PMID 18574131·Int J STD AIDS·2008
8-other
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
PMID 18199854·Mol Interv·2007
6-review
Early average change in tumor size in a phase 2 trial: efficient endpoint or false promise?
PMID 17895470·J Natl Cancer Inst·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 LORNA LN
LOS ANGELES, CA 90049 - Phone
- (310) 472-2706
Quick Facts
- NPI
- 1598914681
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile